BioMarin Pharmaceutical Inc. (FRA:BM8)

BioMarin Pharmaceutical Revenue

BioMarin Pharmaceutical had revenue of $776.13M USD in the quarter ending September 30, 2025, with 4.08% growth. This brings the company's revenue in the last twelve months to $3.09B, up 12.39% year-over-year. In the year 2024, BioMarin Pharmaceutical had annual revenue of $2.85B with 17.97% growth.

• Revenue (ttm): $3.09B
• Revenue Growth: +12.39%
• P/S Ratio: 3.69
• Revenue / Employee: $1.02M
• Employees: 3,040
• Market Cap: 9.74B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.85B	434.69M	17.97%
Dec 31, 2023	2.42B	323.19M	15.42%
Dec 31, 2022	2.10B	249.76M	13.53%
Dec 31, 2021	1.85B	-14.18M	-0.76%
Dec 31, 2020	1.86B	156.41M	9.18%
Dec 31, 2019	1.70B	212.84M	14.27%
Dec 31, 2018	1.49B	177.57M	13.52%
Dec 31, 2017	1.31B	196.79M	17.62%
Dec 31, 2016	1.12B	226.96M	25.50%
Dec 31, 2015	889.90M	140.61M	18.77%
Dec 31, 2014	749.28M	200.80M	36.61%
Dec 31, 2013	548.49M	47.76M	9.54%
Dec 31, 2012	500.72M	59.37M	13.45%
Dec 31, 2011	441.36M	65.09M	17.30%
Dec 31, 2010	376.27M	51.61M	15.90%
Dec 31, 2009	324.66M	28.16M	9.50%
Dec 31, 2008	296.49M	172.82M	139.74%
Dec 31, 2007	123.67M	39.46M	46.86%
Dec 31, 2006	84.21M	58.54M	228.06%
Dec 31, 2005	25.67M	-	-